Health TrialsbyHealthPanel

ECMM Candida Registry - CandiReg

ConditionInvasive Candidiases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Cologne

About this trial

The objective of the European Confederation of Medical Mycology - ECMM Candida Registry (CandiReg) is to overcome the lack of knowledge on epidemiology, clinical course, and molecular characteristics of invasive infections due to invasive Candida infections and to function as a platform for future studies and in case of outbreaks.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Cultural, histopathological, antigen or DNA evidence of invasive fungal infection with Candida species.

Hepatosplenic candidiasis with signs of disseminated Candida infection without culture, histological or microscopic evidence

Case control

Disqualifiers

None

Trial population

Invasive infections caused by Candida species

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

2,000 Participants
are grouped into 1 trial group
Group A: emerging Candida isolates

Trial outcomes

Primary outcomes

1

Incidence

To describe the global incidence of invasive Candida infection

Time frame
up to 100 weeks
2

Mortality

To describe the global mortality of invasive Candida infection

Time frame
up to 100 weeks
3

Molecular characteristics of Candida auris

To describe the molecular characteristics of Candida auris

Time frame
At 90 Days from diagnosis
4

Susceptibility testing

To describe the susceptibility of Candida auris

Time frame
At 90 Days from diagnosis

Secondary outcomes

1

Treatment efficacy of invasive candida infections

Number of participants with treatment failure

Time frame
At 90 Days from diagnosis
2

Treatment efficacy of invasive candida infections

Number of participants with stable disease

Time frame
At 90 Days from diagnosis
3

Treatment efficacy of invasive candida infections

Number of participants with partial response

Time frame
At 90 Days from diagnosis
4

Treatment efficacy of invasive candida infections

Number of participants with complete response

Time frame
At 90 Days from diagnosis

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Cologne

Lead sponsor

Source ClinicalTrials.gov
Apply now